WO2023275083A1 - Transparent cosmetic composition with ascorbic acid and water-soluble uv screening agent - Google Patents
Transparent cosmetic composition with ascorbic acid and water-soluble uv screening agent Download PDFInfo
- Publication number
- WO2023275083A1 WO2023275083A1 PCT/EP2022/067783 EP2022067783W WO2023275083A1 WO 2023275083 A1 WO2023275083 A1 WO 2023275083A1 EP 2022067783 W EP2022067783 W EP 2022067783W WO 2023275083 A1 WO2023275083 A1 WO 2023275083A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- weight
- water
- preferentially
- chosen
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 145
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 82
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 37
- 238000012216 screening Methods 0.000 title claims abstract description 36
- 229960005070 ascorbic acid Drugs 0.000 title claims abstract description 34
- 235000010323 ascorbic acid Nutrition 0.000 title claims abstract description 33
- 239000011668 ascorbic acid Substances 0.000 title claims abstract description 33
- 239000002537 cosmetic Substances 0.000 title claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 claims abstract description 16
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 102000011782 Keratins Human genes 0.000 claims abstract description 7
- 108010076876 Keratins Proteins 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 4
- 125000002091 cationic group Chemical group 0.000 claims description 39
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- 229920000642 polymer Polymers 0.000 claims description 23
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 21
- -1 trimethylammonium halide Chemical class 0.000 claims description 19
- 229920002678 cellulose Polymers 0.000 claims description 18
- 229920000926 Galactomannan Polymers 0.000 claims description 17
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 claims description 16
- 150000001556 benzimidazoles Chemical class 0.000 claims description 16
- 239000011149 active material Substances 0.000 claims description 15
- 239000001913 cellulose Substances 0.000 claims description 15
- 229920006317 cationic polymer Polymers 0.000 claims description 14
- 150000005846 sugar alcohols Chemical class 0.000 claims description 14
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical class OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 claims description 10
- 239000002585 base Substances 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 229960000655 ensulizole Drugs 0.000 claims description 10
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 10
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 claims description 9
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 239000000845 maltitol Substances 0.000 claims description 9
- 235000010449 maltitol Nutrition 0.000 claims description 9
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 9
- 229940035436 maltitol Drugs 0.000 claims description 9
- 239000000600 sorbitol Substances 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- 150000001298 alcohols Chemical class 0.000 claims description 7
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 229920005862 polyol Polymers 0.000 claims description 6
- 150000003077 polyols Chemical class 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 5
- 239000003352 sequestering agent Substances 0.000 claims description 5
- 125000005208 trialkylammonium group Chemical group 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 3
- 229940051250 hexylene glycol Drugs 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 2
- 229940035437 1,3-propanediol Drugs 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 claims description 2
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229940068917 polyethylene glycols Drugs 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 2
- 235000010980 cellulose Nutrition 0.000 description 17
- 244000303965 Cyamopsis psoralioides Species 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 10
- 239000000126 substance Substances 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 125000000129 anionic group Chemical group 0.000 description 4
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 241000282372 Panthera onca Species 0.000 description 3
- HEAHZSUCFKFERC-LRVMPXQBSA-N [(2e)-2-[[4-[(z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-LRVMPXQBSA-N 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- HEAHZSUCFKFERC-UHFFFAOYSA-N ecamsule Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC(C=C1)=CC=C1C=C1C(=O)C2(CS(O)(=O)=O)CCC1C2(C)C HEAHZSUCFKFERC-UHFFFAOYSA-N 0.000 description 3
- 229960003747 ecamsule Drugs 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 3
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 150000002634 lipophilic molecules Chemical class 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- QEHXDDFROMGLSP-VDBFCSKJSA-K trisodium;(2s)-2-[2-[[(1s)-1-carboxy-2-carboxylatoethyl]amino]ethylamino]butanedioate Chemical compound [Na+].[Na+].[Na+].OC(=O)C[C@@H](C([O-])=O)NCCN[C@H](C([O-])=O)CC([O-])=O QEHXDDFROMGLSP-VDBFCSKJSA-K 0.000 description 2
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical group ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- ORWUQAQITKSSRZ-UHFFFAOYSA-N 2-hydroxyethyl 4-[bis[2-(2-hydroxyethoxy)ethyl]amino]benzoate Chemical compound OCCOCCN(CCOCCO)C1=CC=C(C(=O)OCCO)C=C1 ORWUQAQITKSSRZ-UHFFFAOYSA-N 0.000 description 1
- AACHVWXCVWWMSI-UHFFFAOYSA-N 3-hydroxypropyl(trimethyl)azanium Chemical group C[N+](C)(C)CCCO AACHVWXCVWWMSI-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FBXFSONDSA-N Allitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-FBXFSONDSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 125000006539 C12 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PGQAXGHQYGXVDC-UHFFFAOYSA-N dodecyl(dimethyl)azanium;chloride Chemical group Cl.CCCCCCCCCCCCN(C)C PGQAXGHQYGXVDC-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- XFPHFLGZXKHBMU-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxyethyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CCO)CCO)C=C1 XFPHFLGZXKHBMU-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940089468 hydroxyethylpiperazine ethane sulfonic acid Drugs 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 229940048081 trisodium ethylenediamine disuccinate Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/415—Aminophenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- TITLE Transparent cosmetic composition with ascorbic acid and water-soluble UV screening agent
- the present invention relates to a transparent aqueous cosmetic composition, comprising ascorbic acid and at least one water-soluble UV screening agent preferably chosen from benzimidazole derivatives comprising at least one sulfonic radical.
- the present invention relates to a transparent aqueous cosmetic composition
- a transparent aqueous cosmetic composition comprising ascorbic acid, at least one water-soluble UVB screening agent chosen from benzimidazole derivatives comprising at least one sulfonic radical and at least one cationic polymer chosen from cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain.
- vitamin C ascorbic acid
- Ascorbic acid is also known for its antioxidant properties.
- ascorbic acid is introduced into an aqueous medium (such as emulsions or serums) at high contents (i.e. , for example, greater than 1% by weight, preferably greater than 5% by weight), it is difficult to formulate it as it destabilizes and changes drastically in color. This change in color can range up to a brown coloration, which is totally unacceptable to the consumer.
- aqueous medium such as emulsions or serums
- aqueous compositions of serum or solution type which comprise ascorbic acid in the form of a powder to be dissolved at the time of use.
- the disadvantage of products of this type is that the vitamin C ends up by decomposing in the aqueous medium.
- These products thus lose their attractiveness as consumers prefer, for reasons of practicality, serums without prior handling, with the guarantee of stability of color and without chemical decomposition. Consumers also prefer a product of low capacity (for example 10 ml), which makes rapid use possible.
- an aqueous cosmetic composition comprising ascorbic acid which is stable, i.e. which remains of the same color as at the start (generally white) and of the same texture, and which does not decompose the active principle.
- water-soluble UV screening agents preferably benzimidazole derivatives comprising at least one sulfonic radical
- the present invention relates to a cosmetic composition
- a cosmetic composition comprising:
- At least one water-soluble UV screening agent chosen from bis-benzazolyl derivatives, benzimidazole derivatives comprising at least one sulfonic radical, p-aminobenzoic acid derivatives and their mixtures, preferably at a content of at least 0.1% by weight of active material, with respect to the total weight of the composition, said composition having a pH of between 5 and 7.
- the present invention relates to a cosmetic composition
- a cosmetic composition comprising:
- the water-soluble UV screening agent(s) chosen from benzimidazole derivatives comprising at least one sulfonic radical; preferably, the water-soluble UV screening agent(s) is(are) at a content of at least 0.1% by weight of active material, with respect to the total weight of the composition,
- composition having a pH of between 5 and 7.
- the present invention relates to a cosmetic composition
- a cosmetic composition comprising:
- a water-soluble UV screening agent chosen from benzimidazole derivatives comprising at least one sulfonic radical, - at least one cationic polymer chosen from cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain, and
- composition having a pH of between 5 and 7.
- the invention also relates to a cosmetic method for caring for keratin materials, preferably the skin, comprising the application, to said keratin materials, of a composition according to the invention.
- the composition according to the invention is an aqueous solution, more preferentially an aqueous solution with a slightly gelled appearance.
- the composition according to the invention is a single-phase composition. This composition can be referred to as “serum”.
- the term “serum” is understood to mean a composition of fluid texture, of slightly gelled appearance, which is runny, and preferably concentrated in ascorbic acid (i.e. preferably at least 5% by weight of ascorbic acid).
- the composition according to the invention is substantially devoid of surfactants.
- substantially devoid of surfactants is understood to mean that the composition according to the invention exhibits a content of surfactants of less than or equal to 2% by weight, with respect to the total weight of the composition, preferably of less than or equal to 1% by weight.
- the surfactants can preferentially be peptizing agents, the concentration of which is between 0.1% and 2% by weight; they make possible the dissolution of a small amount of oil(s) or of lipophilic compounds or of fragrance(s) (i.e. concentration of fragrance(s) or oil(s) or lipophilic compound(s) of between 0.05% and 2%).
- the composition according to the invention comprises water, which constitutes the aqueous phase.
- the water used can be sterile demineralized water and/or a floral water, such as rose water, cornflower water, camomile water or lime water, and/or a natural thermal or mineral water.
- the composition preferably comprises at least 30% by weight of water, with respect to the total weight of the composition.
- the composition preferably comprises from 30% to 93% by weight of water, with respect to the total weight of the composition, more preferentially from 50% to 90%, more preferentially still from 55% to 70%.
- the aqueous phase can also comprise at least oneorganic solvent which is soluble in water, at 25°C.
- the water-soluble organic solvent is chosen from alcohols, polyols and their mixtures. Mention may be made, among the alcohols, of C 1 -C 10 alcohols, more preferentially C 1 -C 5 alcohols, such as ethanol, isopropanol, propanol and butanol.
- the polyol is preferably chosen from polyols having from 2 to 20 carbon atoms, more preferentially from 2 to 6 carbon atoms, such as glycerol, diglycerol, propylene glycol, isoprene glycol, dipropylene glycol, butylene glycol, hexylene glycol, 1,3-propanediol, pentylene glycol, polyethylene glycols having from 2 to 200 ethylene oxide units and their mixtures.
- polyols having from 2 to 20 carbon atoms, more preferentially from 2 to 6 carbon atoms, such as glycerol, diglycerol, propylene glycol, isoprene glycol, dipropylene glycol, butylene glycol, hexylene glycol, 1,3-propanediol, pentylene glycol, polyethylene glycols having from 2 to 200 ethylene oxide units and their mixtures.
- the water-soluble organic solvent is chosen from polyols, preferably glycerol and/or hexylene glycol and/or pentylene glycol.
- the composition comprises from 1% to 25% by weight of water-soluble organic solvent, with respect to the total weight of the composition, more preferentially from 2% to 30% by weight, more preferentially still from 5% to 20% by weight.
- the ascorbic acid within the meaning of the invention preferably corresponds to L-ascorbic acid, or vitamin C. It has the structure of the formula (I):
- the composition comprises at least 5% by weight of ascorbic acid, with respect to the total weight of the composition, more preferentially at least 7% by weight.
- the composition comprises from 5% to 30% by weight of ascorbic acid, with respect to the total weight of the composition, more preferentially from 7% to 20% by weight.
- the compositions according to the invention are completely transparent, comprise in particular 10% or 12% by weight of ascorbic acid, and exhibit a good chemical stability and an acceptable change in color after 2 months at 45°C, comprising 2-phenylbenzimidazole-5-sulfonic acid.
- This change in color is acceptable because, graded on a color scale ranging from 0 (white, very light) to 9 (black, very dark), the compositions according invention have a grade of from 3.5 to 4, and this grade is lower than that of the reference composition comprising 10% by weight of ascorbic acid in water (graded 4.5, thus greater than 4).
- the composition according to the invention comprises at least one water-soluble UV screening agent, that is at least one water-soluble screening agent capable of absorbing UVA rays and at least one water-soluble screening agent capable of absorbing UVB rays, which is chosen from bis-benzazolyl derivatives, benzimidazole derivatives comprising at least one sulfonic radical, p-aminobenzoic acid derivatives and their mixtures.
- water-soluble screening agent is understood to mean any inorganic or organic screening agent capable of being completely dissolved in molecular form in an aqueous liquid phase or of being dissolved in colloidal form (for example in micellar form) in an aqueous liquid phase.
- UVA Water-soluble screening agents capable of absorbing UV rays from 320 to 400 nm
- Water-soluble screening agents capable of absorbing UV rays from 280 to 320 nm
- - benzimidazole derivatives comprising at least one sulfonic radical, such as 2- phenylbenzimidazole-5-sulfonic acid (I NCI name: Phenylbenzimidazole Sulfonic Acid), p-aminobenzoic acid (PABA) derivatives, such as:
- PEG-25 PABA sold under the name Uvinul P25 by BASF,
- the composition according to the invention comprises at least one water-soluble UV screening agent chosen from benzimidazole derivatives comprising at least one sulfonic radical.
- the benzimidazole derivative comprising at least one sulfonic radical according to the invention is 2-phenylbenzimidazole-5-sulfonic acid (INCI name: Phenylbenzimidazole Sulfonic Acid).
- the benzimidazole derivative comprising at least one sulfonic radical according to the invention is, for example, 2-phenylbenzimidazole-5-sulfonic acid (INCI name: Phenylbenzimidazole Sulfonic Acid) available in particular under the trade name 103089 Neo Heliopan Hydro by Symrise, under the trade name Chemsol-HS by Chemspec Chemicals or under the trade name Eusolex 232 by Merck.
- 2-phenylbenzimidazole-5-sulfonic acid available in particular under the trade name 103089 Neo Heliopan Hydro by Symrise
- Chemsol-HS by Chemspec Chemicals
- Eusolex 232 by Merck.
- the total content of active material of the water-soluble UV screening agent(s) present in the composition according to the invention preferably ranges from 0.1% to 3% by weight, preferably from 0.2% to 1 % by weight and more preferentially from 0.75% to 0.9% by weight, with respect to the total weight of the composition.
- the composition according to the invention comprises ascorbic acid and at least one water-soluble UV screening agent at a ratio of the total content of the water-soluble UV screening agent(s) by weight of active material/total content by weight of ascorbic acid of from 0.006 to 0.2 and more preferentially from 0.013 to 0.06.
- composition according to the invention can additionally comprise a cationic polymer chosen from cationic galactomannan gums (cationic guars) and cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain.
- the cationic polymer according to the invention is chosen from cationic galactomannan gums (cationic guars) and cationic cellulose polymers modified by groups comprising at least one linear fatty chain (preferably Polyquaternium-67).
- the cationic polymer according to the invention can be a cationic galactomannan gum (cationic guar).
- cationic galactomannan gum is understood to mean any galactomannan gum containing cationic groups and/or groups which can be ionized to give cationic groups.
- Galactomannans are polysaccharides composed mainly of galactose and mannose units, in which the mannose units are bonded by a 1 -4-glycoside bond and the galactose branching takes place by means of a 1-6 bridge to the mannose units. Each ring of the galactose or mannose units (or sugar units) carries three free hydroxyl groups available for the chemical reaction.
- Galactomannans are generally found in the endosperm of leguminous seeds, such as guar or locust bean.
- the preferred cationic groups are chosen from those comprising primary, secondary, tertiary and/or quaternary amine groups.
- the cationic galactomannan gums used generally have a weight-average molecular weight of between 500 and 5 c 10 6 approximately and preferably of between 10 3 and 3 c 10 6 approximately.
- the cationic galactomannan gums which can be used according to the present invention are, for example, gums comprising tri(Ci-C4)alkylammonium cationic groups. Preferably, from 2% to 30% by number of the hydroxyl functional groups of these gums carry trialkylammonium cationic groups.
- the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyl trialkylammonium groups, more preferentially a guar gum comprising hydroxypropyl trimethylammonium groups, that is to say a guar gum modified, for example, by 2,3-epoxypropyltrimethylammonium chloride.
- galactomannan gums in particular guar gums modified by cationic groups, are products already known per se and are, for example, described in the patents US 3 589 578 and US 4 031 307. Such products are furthermore sold in particular under the trade names Jaguar Excel, Jaguar C13 S, Jaguar C 15, Jaguar C 17 and Jaguar C162 (Guar Hydroxypropyltrimonium Chloride) by Rhodia, under the name Amilan ® Guar (Guar Hydroxypropyltrimonium Chloride) by Degussa and under the name N-Hance ® 3000 (Guar Hydroxypropyltrimonium Chloride) by Aqualon.
- the cationic polymer according to the invention can alternatively be a cationic cellulose polymer modified by groups comprising at least one linear fatty chain.
- a “cationic cellulose polymer” denotes any non-silicon (not comprising a silicon atom) cellulose polymer containing cationic groups and/or groups which can be ionized to give cationic groups, and preferably not containing anionic groups and/or groups which can be ionized to give anionic groups.
- cellulose polymer is understood to mean, according to the invention, any polysaccharide compound having, in its structure, at least 20 linkages of glucose residues united via b-1 ,4 bonds.
- the cellulose polymer can be associative, that is to say have, in its structure, at least one C8-C30 fatty chain.
- the cationic cellulose polymers capable of being used preferably have a weight-average molar mass (Mw) of between 5000 and 5 c 10 6 approximately and preferably of between 10 3 and 3x10 6 approximately.
- quaternized celluloses of quaternized celluloses modified by groups comprising at least one linear fatty chain, such as linear alkyl, linear or branched arylalkyl or linear alkylaryl, preferably linear alkyl, groups, these groups comprising at least 8 carbon atoms, in particular from 8 to 30 carbon atoms, better still from 10 to 24, indeed even from 10 to 14, carbon atoms; or mixtures of these.
- groups comprising at least one linear fatty chain, such as linear alkyl, linear or branched arylalkyl or linear alkylaryl, preferably linear alkyl, groups, these groups comprising at least 8 carbon atoms, in particular from 8 to 30 carbon atoms, better still from 10 to 24, indeed even from 10 to 14, carbon atoms; or mixtures of these.
- quaternized hydroxyethylcelluloses modified by groups comprising at least one linear fatty chain, such as linear alkyl, linear arylalkyl or linear alkylaryl, preferably linear alkyl, groups, these groups comprising at least 8 carbon atoms, in particular from 8 to 30 carbon atoms, better still from 10 to 24, indeed even from 10 to 14, carbon atoms; or mixtures of these.
- groups comprising at least one linear fatty chain, such as linear alkyl, linear arylalkyl or linear alkylaryl, preferably linear alkyl, groups, these groups comprising at least 8 carbon atoms, in particular from 8 to 30 carbon atoms, better still from 10 to 24, indeed even from 10 to 14, carbon atoms; or mixtures of these.
- - R represents an ammonium group -I TRaRbRc Q in which Ra, Rb and Rc, which are identical or different, represent a hydrogen atom or a linear C1-C30 alkyl, preferably an alkyl, and Q represents an anionic counterion, such as a halide, for example a chloride or bromide;
- R’ represents an ammonium group -N + R’aR’bR’c Q’- in which R’a, R’b and R’c, which are identical or different, represent a hydrogen atom or a linear C1-C30 alkyl and Q’- represents an anionic counterion, such as a halide, for example a chloride or bromide; preferably an alkyl; it being understood that at least one of the Ra, Rb, Rc, R'a, R'b and R'c radicals represents a linear C8-C30 alkyl;
- n, x and y which are identical or different, represent an integer of between 1 and 10000.
- at least one of the Ra, Rb, Rc, R'a, R'b and R'c radicals represents a linear C8-C30, better still C10-C24, indeed even C10-C14, alkyl; mention may in particular be made of the dodecyl (C12) radical.
- the other radical(s) represent(s) a linear C1-C4 alkyl, in particular methyl.
- just one of the Ra, Rb, Rc, R'a, R'b and R'c radicals represents a linear C8-C30, better still C10-C24, indeed even C10-C14, alkyl; mention may in particular be made of the dodecyl (C12) radical.
- all the other radicals represent a linear C1-C4 alkyl, in particular methyl.
- R can be a group chosen from -N + (CH3)3 Q’- and -N + (Ci2H25)(CH3)2 Q 1 , preferably an -N + (CH3)3 Q 1 group. Even better still, R' can be an -N + (Ci2H25)(CH3)2 Q 1 group.
- the percentage of nitrogen can vary from 0.1% to 10% by weight, with respect to the total weight of polymer, preferably from 0.2% to 5% by weight and better still from 0.5% to 3% by weight.
- C18 alkyl such as the product Crodacel QS®, which are sold by Croda.
- R represents a trimethylammonium halide and R' represents a dimethyldodecylammonium halide; preferentially, R represents trimethylammonium chloride -N + (CH3)3 Cl and R' represents dimethyldodecylammonium chloride -N + (CH3)2(Ci2H2s) Cl .
- This type of polymer is known under the INCI name: Polyquaternium-67; mention may be made, as commercial products, of the Softcat Polymer SL® polymers, such as SL-100, SL-60, SL-30, SL-5 and SX-1300X, from Amerchol/Dow Chemical.
- the cationic cellulose polymer is chosen from hydroxyethylcelluloses which have reacted with a trimethylammonium epoxide and a lauryldimethylammonium epoxide (INCI name: Polyquaternium-67).
- Softcat Polymer SL-100 or Softcat Polymer SX-1300X by Amerchol is preferably sold under the name Softcat Polymer SL-100 or Softcat Polymer SX-1300X by Amerchol.
- the cosmetic composition according to the invention comprises at least one cationic polymer chosen from guar gums comprising trialkylammonium cationic groups and quaternized hydroxyethylcelluloses modified by groups comprising at least one linear fatty chain; preferably from hydroxyethylcelluloses of formula (lb) as defined above in which R represents the trimethylammonium halide and R' represents the dimethyldodecylammonium halide, and preferably from guar hydroxypropyl trimethylammonium chloride and hydroxyethylcelluloses which have reacted with a trimethylammonium epoxide and a lauryldimethylammonium epoxide (INCI name: Polyquaternium-67).
- the total content of active material of the cationic polymer(s) which can be present in the composition according to the invention preferably ranges from 0.05% to 5% by weight, preferably from 0.3% to 3% by weight and more preferentially from 0.4% to 2% by weight, with respect to the total weight of the composition.
- composition according to the invention additionally comprises at least one sugar alcohol.
- sugar alcohol denotes a sugar comprising only hydroxyl functional groups. These sugar alcohols differ from ketoses and aldoses, which comprise ketone or aldehyde functional groups. Sugar alcohols are in particular described in the encyclopedia Kirk- Othmer Encyclopedia of Chemical Technology, John Wiley and Sons, article “Sugar Alcohols”, 2005.
- sugar alcohols which can be used in the compositions according to the invention correspond to the general formula:
- n an integer ranging from 2 to 5.
- the sugar alcohol can be chosen from erythritol, sorbitol, threitol, ribitol, arabinitol, allitol, dulcitol, iditol, altritol, lactitol, maltitol, mannitol, xylitol and the mixtures of these compounds.
- the sugar alcohol can be chosen from maltitol, sorbitol and the mixture of these compounds.
- the composition according to the invention comprises maltitol, sorbitol or their mixture and preferentially comprises maltitol and sorbitol.
- the total content of sugar alcohol(s), preferably of maltitol and sorbitol, which can be present in the composition according to the invention preferably ranges from 0.05% to 5% by weight of active material, preferably from 0.075% to 3% by weight of active material and more preferentially from 0.15% to 2.25% by weight of active material, with respect to the total weight of the composition. pH of the composition
- the composition according to the invention exhibits a pH of from 5.0 to 7.0.
- the pH of the composition is between 5.5 and 6.5.
- the cosmetic composition according to the invention comprises at least one base.
- the base is used in particular to increase the final pH of the composition between 5.0 and 7.0, preferably between 5.5 and 6.5.
- the base can be chosen from inorganic bases, such as, for example, alkali metal hydroxides, sodium hydroxide or potassium hydroxide.
- the base of the composition is an alkali metal hydroxide, preferably sodium hydroxide or potassium hydroxide. This is because these bases are more advantageous than nitrogenous bases, such as triethanolamine, with regard to the stabilization of the color (i.e. less yellowing).
- the base of the composition according to the invention is present in a base:ascorbic acid ratio by weight ranging from 0.22 to 0.30.
- the composition can also comprise one or more additive(s) conventionally used in cosmetic compositions, such as, for example, active principles, sequestering agents, glycols, preservatives or also fragrances.
- active principles such as, for example, active principles, sequestering agents, glycols, preservatives or also fragrances.
- preference is given to adenosine, salicylic acid, glycolic acid, niacinamide (vitamin B3), tocopherol or also fragrances.
- the composition according to the invention can comprise at least one sequestering agent. Mention may be made, among the preferred sequestering agents, of the salts of ethylenediaminedisuccinic acid.
- Ethylenediaminedisuccinic acid is a compound of formula (II): [Chem 3]
- the salt of ethylenediaminedisuccinic acid is chosen from the alkali metal salts, such as potassium salts and sodium salts, ammonium salts and amine salts.
- the alkali metal salts of ethylenediaminedisuccinic acid are more particularly preferred.
- the salt of ethylenediaminedisuccinic acid used according to the invention is trisodium ethylenediaminedisuccinate.
- Such a compound is, for example, that sold under the name Natrlquest® E30 by Innospec Active Chemicals, or also that sold under the name Octaquest E30 ® by Octel Performance Chemicals.
- the composition according to the invention comprises from 0.01% to 2.5% by weight, preferably from 0.05% to 1.5% by weight, more preferentially from 0.07% to 0.3% by weight, of salt of ethylenediaminedisuccinic acid, with respect to the total weight of the composition.
- the content of salt of ethylenediaminedisuccinic acid corresponds to the content of active material, also known as solids content, of salt of ethylenediaminedisuccinic acid introduced into the composition.
- the salt of ethylenediaminedisuccinic acid can be introduced into the composition dissolved in water, in particular at a content ranging from 25% to 50% by weight, preferably from 35% to 40% by weight, in the water.
- composition according to the invention can comprise at least one glycol, preferably caprylyl glycol.
- the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.2% to 1.5% by weight, of glycol(s), with respect to the total weight of the composition.
- composition according to the invention can comprise at least one preservative. Mention may be made, among the preferred preservatives, of hydroxyacetophenone, phenoxyethanol and their mixtures. Preferably, the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.5% to 1.5% by weight, more preferentially from 0.7% to 1% by weight, of preservative(s), with respect to the total weight of the composition.
- the composition of the present invention is transparent.
- transparent composition is understood to mean, within the meaning of the present invention, a composition exhibiting a turbidity value of less than 200 NTU, preferably of less than 150 NTU, preferably of less than 100 NTU.
- the turbidity of the compositions is at least equal to 1 NTU.
- the NTU (nephelometric turbidity unit) is the unit of measurement of the turbidity of a composition.
- the measurement of the turbidity is carried out, for example, with a 21 OOP model turbidimeter from Hach, the tubes used for the measurement being referenced AR397A cat 24347-06.
- the measurements are carried out at ambient temperature (from 20°C to 25°C).
- the composition is transparent and exhibits a turbidity value of between 1 and 200 NTU, preferably between 1 and 150 NTU, preferably of less than 100 NTU.
- the invention also relates to a cosmetic method for caring for keratin materials, preferably the skin, comprising the application, to said keratin materials, of a composition according to the invention.
- Example 1 Influence of water-soluble UV screening agent on the stabilization of the color of an aqueous solution comprisinq 10% and 12% bv weiqht of vitamin C
- the preparation is carried out of gelled aqueous solutions comprising 10% or 12% by weight of ascorbic acid, having a pH equal to 6, the pH having been adjusted with sodium hydroxide (NaOH);
- a water-soluble UVA screening agent outside the definition of water-soluble UV screening agents according to the present invention, which is Terephthalylidene Dicamphor Sulfonic Acid available under the name Mexoryl SX from Chimex (comparative Formula B); comprising 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (I NCI name:
- Terephthalylidene Dicamphor Sulfonic Acid which comprises a sulfonate functional group, is not compatible in terms of chemical stability of the compositions according to the invention comprising 1% by weight of ascorbic acid and thus does not make possible the reduction in color.
- the solutions obtained are all stable, in particular after storage at 45°C for 2 months, and show an acceptable loss of vitamin C.
- benzimidazole derivatives comprising at least one sulfonic radical, for example 2-phenylbenzimidazole-5-sulfonic acid (I NCI name: Phenylbenzimidazole Sulfonic Acid), makes it possible to stabilize the color of solutions of vitamin C.
- water-soluble UV screening agents such as benzimidazole derivatives comprising at least one sulfonic radical, make it possible simultaneously to combine the stabilization of the color and the achievement of a completely transparent serum.
- Example 3 Compositions according to the invention
- Phase A in the main reactor:
- the water is inserted at ambient temperature.
- the ascorbic acid is inserted and mechanical stirring is carried out.
- Phase B in an auxiliary reactor:
- Phase C in an auxiliary reactor:
- the 3 phases are combined in the main vessel and the q.s. is made with water.
- compositions E to J according to the invention comprising at least one water- soluble UV screening agent defined according to the invention, in particular benzimidazole derivatives comprising at least one sulfonic radical, such as 2-phenylbenzimidazole-5- sulfonicacid (I NCI name: Phenylbenzimidazole Sulfonic Acid), and which can also comprise at least one cationic polymer, such as cationic cellulose polymers (Polyquaternium-67), and optionally in addition at least one sugar alcohol, such as maltitol and/or sorbitol, exhibit a stabilization of the color while being completely transparent.
- benzimidazole derivatives comprising at least one sulfonic radical, such as 2-phenylbenzimidazole-5- sulfonicacid (I NCI name: Phenylbenzimidazole Sulfonic Acid)
- at least one cationic polymer such as cationic cellulose polymers (Polyquaternium-67)
- compositions according to the invention exhibit in particular the following properties:
Abstract
A subject of the present invention is a cosmetic composition comprising: - at least 30% by weight of water, with respect to the total weight of the composition, - at least 5% by weight of ascorbic acid, with respect to the total weight of the composition, - at least one water-soluble UV screening agent chosen from bis-benzazolyl derivatives, benzimidazole derivatives comprising at least one sulfonic radical, p-aminobenzoic acid derivatives and their mixtures, preferably chosen from benzimidazole derivatives comprising at least one sulfonic radical, said composition having a pH of between 5 and 7, preferably between 5.5 and 6.5. Another subject of the invention is a cosmetic method for caring for keratin materials using this composition.
Description
DESCRIPTION
TITLE: Transparent cosmetic composition with ascorbic acid and water-soluble UV screening agent
The present invention relates to a transparent aqueous cosmetic composition, comprising ascorbic acid and at least one water-soluble UV screening agent preferably chosen from benzimidazole derivatives comprising at least one sulfonic radical.
Preferably, the present invention relates to a transparent aqueous cosmetic composition comprising ascorbic acid, at least one water-soluble UVB screening agent chosen from benzimidazole derivatives comprising at least one sulfonic radical and at least one cationic polymer chosen from cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain.
In cosmetic applications, it is common to add ascorbic acid (vitamin C) as active principle which regenerates the skin, by virtue of the stimulation of the synthesis of collagen responsible for the firmness of the skin, or also depigmenting agent, as this vitamin reduces the production of melanin responsible for liver spots. Ascorbic acid is also known for its antioxidant properties.
However, when ascorbic acid is introduced into an aqueous medium (such as emulsions or serums) at high contents (i.e. , for example, greater than 1% by weight, preferably greater than 5% by weight), it is difficult to formulate it as it destabilizes and changes drastically in color. This change in color can range up to a brown coloration, which is totally unacceptable to the consumer.
This is why there are found, on the market, aqueous compositions of serum or solution type which comprise ascorbic acid in the form of a powder to be dissolved at the time of use. The disadvantage of products of this type is that the vitamin C ends up by decomposing in the aqueous medium. These products thus lose their attractiveness as consumers prefer, for reasons of practicality, serums without prior handling, with the guarantee of stability of color and without chemical decomposition. Consumers also prefer a product of low capacity (for example 10 ml), which makes rapid use possible.
There thus exists a need for an aqueous cosmetic composition comprising ascorbic acid which is stable, i.e. which remains of the same color as at the start (generally white) and of the same texture, and which does not decompose the active principle.
Surprisingly, the Applicant Company has demonstrated that water-soluble UV screening agents, preferably benzimidazole derivatives comprising at least one sulfonic radical, make it possible to limit the degradation of the color of the compositions comprising ascorbic acid, over time and at temperature, while retaining the stability of the compositions which are obtained.
Thus, the present invention relates to a cosmetic composition comprising:
- at least 30% by weight of water, with respect to the total weight of the composition,
- at least 5% by weight of ascorbic acid, with respect to the total weight of the composition,
- at least one water-soluble UV screening agent chosen from bis-benzazolyl derivatives, benzimidazole derivatives comprising at least one sulfonic radical, p-aminobenzoic acid derivatives and their mixtures, preferably at a content of at least 0.1% by weight of active material, with respect to the total weight of the composition, said composition having a pH of between 5 and 7.
Preferably, the present invention relates to a cosmetic composition comprising:
- at least 30% by weight of water, with respect to the total weight of the composition,
- at least 5% by weight of ascorbic acid, with respect to the total weight of the composition,
- at least one water-soluble UV screening agent chosen from benzimidazole derivatives comprising at least one sulfonic radical; preferably, the water-soluble UV screening agent(s) is(are) at a content of at least 0.1% by weight of active material, with respect to the total weight of the composition,
- at least one cationic polymer chosen from cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain, said composition having a pH of between 5 and 7.
More preferentially, the present invention relates to a cosmetic composition comprising:
- at least 30% by weight of water, with respect to the total weight of the composition,
- at least 5% by weight of ascorbic acid, with respect to the total weight of the composition,
- at least 0.1% by weight of active material of a water-soluble UV screening agent chosen from benzimidazole derivatives comprising at least one sulfonic radical,
- at least one cationic polymer chosen from cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain, and
- at least one sugar alcohol, preferably maltitol and/or sorbitol, said composition having a pH of between 5 and 7.
The invention also relates to a cosmetic method for caring for keratin materials, preferably the skin, comprising the application, to said keratin materials, of a composition according to the invention. Preferably, the composition according to the invention is an aqueous solution, more preferentially an aqueous solution with a slightly gelled appearance. Preferably, the composition according to the invention is a single-phase composition. This composition can be referred to as “serum”. The term “serum” is understood to mean a composition of fluid texture, of slightly gelled appearance, which is runny, and preferably concentrated in ascorbic acid (i.e. preferably at least 5% by weight of ascorbic acid).
Preferably, the composition according to the invention is substantially devoid of surfactants. The term “substantially devoid of surfactants” is understood to mean that the composition according to the invention exhibits a content of surfactants of less than or equal to 2% by weight, with respect to the total weight of the composition, preferably of less than or equal to 1% by weight. The surfactants can preferentially be peptizing agents, the concentration of which is between 0.1% and 2% by weight; they make possible the dissolution of a small amount of oil(s) or of lipophilic compounds or of fragrance(s) (i.e. concentration of fragrance(s) or oil(s) or lipophilic compound(s) of between 0.05% and 2%).
Aqueous phase
The composition according to the invention comprises water, which constitutes the aqueous phase. The water used can be sterile demineralized water and/or a floral water, such as rose water, cornflower water, camomile water or lime water, and/or a natural thermal or mineral water.
The composition preferably comprises at least 30% by weight of water, with respect to the total weight of the composition.
The composition preferably comprises from 30% to 93% by weight of water, with respect to the total weight of the composition, more preferentially from 50% to 90%, more preferentially still from 55% to 70%. The aqueous phase can also comprise at least oneorganic solvent which is soluble in water, at 25°C.
Preferably, the water-soluble organic solvent is chosen from alcohols, polyols and their mixtures. Mention may be made, among the alcohols, of C1-C10 alcohols, more preferentially C1-C5 alcohols, such as ethanol, isopropanol, propanol and butanol.
The polyol is preferably chosen from polyols having from 2 to 20 carbon atoms, more preferentially from 2 to 6 carbon atoms, such as glycerol, diglycerol, propylene glycol, isoprene glycol, dipropylene glycol, butylene glycol, hexylene glycol, 1,3-propanediol, pentylene glycol, polyethylene glycols having from 2 to 200 ethylene oxide units and their mixtures.
Preferably, the water-soluble organic solvent is chosen from polyols, preferably glycerol and/or hexylene glycol and/or pentylene glycol.
Preferably, the composition comprises from 1% to 25% by weight of water-soluble organic solvent, with respect to the total weight of the composition, more preferentially from 2% to 30% by weight, more preferentially still from 5% to 20% by weight. Ascorbic acid
The ascorbic acid within the meaning of the invention preferably corresponds to L-ascorbic acid, or vitamin C. It has the structure of the formula (I):
The composition comprises at least 5% by weight of ascorbic acid, with respect to the total weight of the composition, more preferentially at least 7% by weight.
Preferably, the composition comprises from 5% to 30% by weight of ascorbic acid, with respect to the total weight of the composition, more preferentially from 7% to 20% by weight.
As shown in the examples, surprisingly, the compositions according to the invention are completely transparent, comprise in particular 10% or 12% by weight of ascorbic acid, and exhibit a good chemical stability and an acceptable change in color after 2 months at 45°C, comprising 2-phenylbenzimidazole-5-sulfonic acid. This change in color is acceptable because, graded on a color scale ranging from 0 (white, very light) to 9 (black, very dark), the compositions according invention have a grade of from 3.5 to 4, and this grade is lower than that of the reference composition comprising 10% by weight of ascorbic acid in water (graded 4.5, thus greater than 4).
Water-soluble UV screening agent The composition according to the invention comprises at least one water-soluble UV screening agent, that is at least one water-soluble screening agent capable of absorbing UVA rays and at least one water-soluble screening agent capable of absorbing UVB rays, which is chosen from bis-benzazolyl derivatives, benzimidazole derivatives comprising at least one sulfonic radical, p-aminobenzoic acid derivatives and their mixtures. The term "water-soluble screening agent" is understood to mean any inorganic or organic screening agent capable of being completely dissolved in molecular form in an aqueous liquid phase or of being dissolved in colloidal form (for example in micellar form) in an aqueous liquid phase.
Water-soluble screening agents capable of absorbing UV rays from 320 to 400 nm (UVA)
Mention may be made, among the water-soluble screening agents capable of absorbing UVA rays according to the invention, of:
- bis-benzazolyl derivatives such as described in EP 669323 and US 2463264 and more particularly the compound Disodium Phenyl Dibenzimidazole Tetrasulfonate sold under the trade name Neo Heliopan AP by Haarmann & Reimer.
Water-soluble screening agents capable of absorbing UV rays from 280 to 320 nm
(UVB)
Mention may be made, among the water-soluble screening agents capable of absorbing UVB rays according to the invention, of:
- benzimidazole derivatives comprising at least one sulfonic radical, such as 2- phenylbenzimidazole-5-sulfonic acid (I NCI name: Phenylbenzimidazole Sulfonic Acid), p-aminobenzoic acid (PABA) derivatives, such as:
PABA,
Glyceryl PABA and
PEG-25 PABA, sold under the name Uvinul P25 by BASF,
DEA Methoxycinnamate.
Preferably, the composition according to the invention comprises at least one water-soluble UV screening agent chosen from benzimidazole derivatives comprising at least one sulfonic radical.
Preferably, the benzimidazole derivative comprising at least one sulfonic radical according to the invention is 2-phenylbenzimidazole-5-sulfonic acid (INCI name: Phenylbenzimidazole Sulfonic Acid).
The benzimidazole derivative comprising at least one sulfonic radical according to the invention is, for example, 2-phenylbenzimidazole-5-sulfonic acid (INCI name: Phenylbenzimidazole Sulfonic Acid) available in particular under the trade name 103089 Neo Heliopan Hydro by Symrise, under the trade name Chemsol-HS by Chemspec Chemicals or under the trade name Eusolex 232 by Merck.
The total content of active material of the water-soluble UV screening agent(s) present in the composition according to the invention preferably ranges from 0.1% to 3% by weight, preferably from 0.2% to 1 % by weight and more preferentially from 0.75% to 0.9% by weight, with respect to the total weight of the composition.
In a preferred embodiment, the composition according to the invention comprises ascorbic acid and at least one water-soluble UV screening agent at a ratio of the total content of the water-soluble UV screening agent(s) by weight of active material/total content by weight of ascorbic acid of from 0.006 to 0.2 and more preferentially from 0.013 to 0.06.
Cationic polymer chosen from cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain
In a preferred embodiment, the composition according to the invention can additionally comprise a cationic polymer chosen from cationic galactomannan gums (cationic guars) and cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain.
The cationic polymer according to the invention is chosen from cationic galactomannan gums (cationic guars) and cationic cellulose polymers modified by groups comprising at least one linear fatty chain (preferably Polyquaternium-67).
This is because, as shown in the examples, these polymers are more favorable to the cosmetic quality and to the stability of the compositions.
The cationic polymer according to the invention can be a cationic galactomannan gum (cationic guar). The term “cationic galactomannan gum" is understood to mean any galactomannan gum containing cationic groups and/or groups which can be ionized to give cationic groups.
Galactomannans are polysaccharides composed mainly of galactose and mannose units, in which the mannose units are bonded by a 1 -4-glycoside bond and the galactose branching takes place by means of a 1-6 bridge to the mannose units. Each ring of the galactose or mannose units (or sugar units) carries three free hydroxyl groups available for the chemical reaction. Galactomannans are generally found in the endosperm of leguminous seeds, such as guar or locust bean.
The preferred cationic groups are chosen from those comprising primary, secondary, tertiary and/or quaternary amine groups.
The cationic galactomannan gums used generally have a weight-average molecular weight of between 500 and 5 c 106 approximately and preferably of between 103 and 3 c 106 approximately.
The cationic galactomannan gums which can be used according to the present invention are, for example, gums comprising tri(Ci-C4)alkylammonium cationic groups. Preferably, from 2% to 30% by number of the hydroxyl functional groups of these gums carry trialkylammonium cationic groups.
Mention may very particularly be made, among these trialkylammonium groups, of the trimethylammonium and triethylammonium groups.
More preferentially still, these groups represent from 5% to 20% by weight of the total weight of the modified galactomannan gum.
According to the invention, the cationic galactomannan gum is preferably a guar gum comprising hydroxypropyl trialkylammonium groups, more preferentially a guar gum comprising hydroxypropyl trimethylammonium groups, that is to say a guar gum modified, for example, by 2,3-epoxypropyltrimethylammonium chloride.
These galactomannan gums, in particular guar gums modified by cationic groups, are products already known per se and are, for example, described in the patents US 3 589 578 and US 4 031 307. Such products are furthermore sold in particular under the trade names Jaguar Excel, Jaguar C13 S, Jaguar C 15, Jaguar C 17 and Jaguar C162 (Guar Hydroxypropyltrimonium Chloride) by Rhodia, under the name Amilan® Guar (Guar Hydroxypropyltrimonium Chloride) by Degussa and under the name N-Hance® 3000 (Guar Hydroxypropyltrimonium Chloride) by Aqualon.
The cationic polymer according to the invention can alternatively be a cationic cellulose polymer modified by groups comprising at least one linear fatty chain. Within the meaning of the present invention, a “cationic cellulose polymer” denotes any non-silicon (not comprising a silicon atom) cellulose polymer containing cationic groups and/or groups which can be ionized to give cationic groups, and preferably not containing anionic groups and/or groups which can be ionized to give anionic groups.
The term “cellulose" polymer is understood to mean, according to the invention, any polysaccharide compound having, in its structure, at least 20 linkages of glucose residues united via b-1 ,4 bonds. The cellulose polymer can be associative, that is to say have, in its structure, at least one C8-C30 fatty chain.
The cationic cellulose polymers capable of being used preferably have a weight-average molar mass (Mw) of between 5000 and 5c106 approximately and preferably of between 103 and 3x106 approximately.
Mention may more particularly be made, among cationic celluloses, of cellulose ethers comprising quaternary ammonium groups modified by groups comprising at least one linear fatty chain.
Mention may in particular be made, among quaternized celluloses, of quaternized celluloses modified by groups comprising at least one linear fatty chain, such as linear alkyl, linear or branched arylalkyl or linear alkylaryl, preferably linear alkyl, groups, these groups comprising at least 8 carbon atoms, in particular from 8 to 30 carbon atoms, better still from 10 to 24, indeed even from 10 to 14, carbon atoms; or mixtures of these.
Preferably, mention may be made of quaternized hydroxyethylcelluloses modified by groups comprising at least one linear fatty chain, such as linear alkyl, linear arylalkyl or linear
alkylaryl, preferably linear alkyl, groups, these groups comprising at least 8 carbon atoms, in particular from 8 to 30 carbon atoms, better still from 10 to 24, indeed even from 10 to 14, carbon atoms; or mixtures of these.
Preferentially, mention may be made of the hydroxyethylcelluloses of formula (lb): [Chem 2]
in which:
- R represents an ammonium group -I TRaRbRc Q in which Ra, Rb and Rc, which are identical or different, represent a hydrogen atom or a linear C1-C30 alkyl, preferably an alkyl, and Q represents an anionic counterion, such as a halide, for example a chloride or bromide;
- R’ represents an ammonium group -N+R’aR’bR’c Q’- in which R’a, R’b and R’c, which are identical or different, represent a hydrogen atom or a linear C1-C30 alkyl and Q’- represents an anionic counterion, such as a halide, for example a chloride or bromide; preferably an alkyl; it being understood that at least one of the Ra, Rb, Rc, R'a, R'b and R'c radicals represents a linear C8-C30 alkyl;
- n, x and y, which are identical or different, represent an integer of between 1 and 10000. Preferably, in the formula (lb), at least one of the Ra, Rb, Rc, R'a, R'b and R'c radicals represents a linear C8-C30, better still C10-C24, indeed even C10-C14, alkyl; mention may in particular be made of the dodecyl (C12) radical. Preferably, the other radical(s) represent(s) a linear C1-C4 alkyl, in particular methyl.
Preferably, in the formula (lb), just one of the Ra, Rb, Rc, R'a, R'b and R'c radicals represents a linear C8-C30, better still C10-C24, indeed even C10-C14, alkyl; mention may in particular be made of the dodecyl (C12) radical. Preferably, all the other radicals represent a linear C1-C4 alkyl, in particular methyl.
Even better still, R can be a group chosen from -N+(CH3)3 Q’- and -N+(Ci2H25)(CH3)2 Q1 , preferably an -N+(CH3)3 Q1 group.
Even better still, R' can be an -N+(Ci2H25)(CH3)2 Q1 group.
The percentage of nitrogen can vary from 0.1% to 10% by weight, with respect to the total weight of polymer, preferably from 0.2% to 5% by weight and better still from 0.5% to 3% by weight.
Mention may in particular be made of the polymers having the INCI name:
- Polyquaternium-24, such as the product Quatrisoft LM 200®, sold by Amerchol/Dow Chemical;
- PG-Hydroxyethylcellulose Cocodimonium Chloride, such as the product Crodacel QM®;
- PG-Hydroxyethylcellulose Lauryldimonium Chloride (C12 alkyl), such as the product Crodacel QL®; and
- PG-Hydroxyethylcellulose Stearyldimonium Chloride (C18 alkyl), such as the product Crodacel QS®, which are sold by Croda.
Mention may also be made of the hydroxyethylcelluloses of formula (lb) in which R represents a trimethylammonium halide and R' represents a dimethyldodecylammonium halide; preferentially, R represents trimethylammonium chloride -N+(CH3)3 Cl and R' represents dimethyldodecylammonium chloride -N+(CH3)2(Ci2H2s) Cl . This type of polymer is known under the INCI name: Polyquaternium-67; mention may be made, as commercial products, of the Softcat Polymer SL® polymers, such as SL-100, SL-60, SL-30, SL-5 and SX-1300X, from Amerchol/Dow Chemical.
More particularly, the cationic cellulose polymer is chosen from hydroxyethylcelluloses which have reacted with a trimethylammonium epoxide and a lauryldimethylammonium epoxide (INCI name: Polyquaternium-67).
It is preferably sold under the name Softcat Polymer SL-100 or Softcat Polymer SX-1300X by Amerchol.
According to a preferred embodiment, the cosmetic composition according to the invention comprises at least one cationic polymer chosen from guar gums comprising trialkylammonium cationic groups and quaternized hydroxyethylcelluloses modified by groups comprising at least one linear fatty chain; preferably from hydroxyethylcelluloses of formula (lb) as defined above in which R represents the trimethylammonium halide and R' represents the dimethyldodecylammonium halide,
and preferably from guar hydroxypropyl trimethylammonium chloride and hydroxyethylcelluloses which have reacted with a trimethylammonium epoxide and a lauryldimethylammonium epoxide (INCI name: Polyquaternium-67).
The total content of active material of the cationic polymer(s) which can be present in the composition according to the invention preferably ranges from 0.05% to 5% by weight, preferably from 0.3% to 3% by weight and more preferentially from 0.4% to 2% by weight, with respect to the total weight of the composition.
Sugar alcohol
In a preferred embodiment, the composition according to the invention additionally comprises at least one sugar alcohol.
The term “sugar alcohol” denotes a sugar comprising only hydroxyl functional groups. These sugar alcohols differ from ketoses and aldoses, which comprise ketone or aldehyde functional groups. Sugar alcohols are in particular described in the encyclopedia Kirk- Othmer Encyclopedia of Chemical Technology, John Wiley and Sons, article “Sugar Alcohols”, 2005.
Preferably, the sugar alcohols which can be used in the compositions according to the invention correspond to the general formula:
[Chem 3]
OH-CH2-(CHOH)n-CH2-OH with n an integer ranging from 2 to 5.
The sugar alcohol can be chosen from erythritol, sorbitol, threitol, ribitol, arabinitol, allitol, dulcitol, iditol, altritol, lactitol, maltitol, mannitol, xylitol and the mixtures of these compounds. Preferably, the sugar alcohol can be chosen from maltitol, sorbitol and the mixture of these compounds.
Preferably, the composition according to the invention comprises maltitol, sorbitol or their mixture and preferentially comprises maltitol and sorbitol.
The total content of sugar alcohol(s), preferably of maltitol and sorbitol, which can be present in the composition according to the invention preferably ranges from 0.05% to 5% by weight of active material, preferably from 0.075% to 3% by weight of active material and more preferentially from 0.15% to 2.25% by weight of active material, with respect to the total weight of the composition.
pH of the composition
The composition according to the invention exhibits a pH of from 5.0 to 7.0. Advantageously, the pH of the composition is between 5.5 and 6.5.
This is because such a pH limits the deterioration in the color of the ascorbic acid and thus limits the transformation of a colorless composition into a composition which becomes yellow to brown over time. When the pH is less than 5, the composition becomes brown and, graded on a color scale ranging from 0 (white, very light) to 9 (black, very dark), it exhibits a grade above 8. Preferably, the cosmetic composition according to the invention comprises at least one base.
The base is used in particular to increase the final pH of the composition between 5.0 and 7.0, preferably between 5.5 and 6.5. The base can be chosen from inorganic bases, such as, for example, alkali metal hydroxides, sodium hydroxide or potassium hydroxide.
Preferably, the base of the composition is an alkali metal hydroxide, preferably sodium hydroxide or potassium hydroxide. This is because these bases are more advantageous than nitrogenous bases, such as triethanolamine, with regard to the stabilization of the color (i.e. less yellowing).
Preferably, the base of the composition according to the invention is present in a base:ascorbic acid ratio by weight ranging from 0.22 to 0.30.
The composition can also comprise one or more additive(s) conventionally used in cosmetic compositions, such as, for example, active principles, sequestering agents, glycols, preservatives or also fragrances. Preferably, among the active principles which can be used, preference is given to adenosine, salicylic acid, glycolic acid, niacinamide (vitamin B3), tocopherol or also fragrances.
The composition according to the invention can comprise at least one sequestering agent. Mention may be made, among the preferred sequestering agents, of the salts of ethylenediaminedisuccinic acid.
Preferably, the salt of ethylenediaminedisuccinic acid is chosen from the alkali metal salts, such as potassium salts and sodium salts, ammonium salts and amine salts. The alkali metal salts of ethylenediaminedisuccinic acid are more particularly preferred.
Preferably, the salt of ethylenediaminedisuccinic acid used according to the invention is trisodium ethylenediaminedisuccinate.
Such a compound is, for example, that sold under the name Natrlquest® E30 by Innospec Active Chemicals, or also that sold under the name Octaquest E30® by Octel Performance Chemicals.
Preferably, the composition according to the invention comprises from 0.01% to 2.5% by weight, preferably from 0.05% to 1.5% by weight, more preferentially from 0.07% to 0.3% by weight, of salt of ethylenediaminedisuccinic acid, with respect to the total weight of the composition.
It is understood that the content of salt of ethylenediaminedisuccinic acid corresponds to the content of active material, also known as solids content, of salt of ethylenediaminedisuccinic acid introduced into the composition.
According to a specific alternative embodiment, the salt of ethylenediaminedisuccinic acid can be introduced into the composition dissolved in water, in particular at a content ranging from 25% to 50% by weight, preferably from 35% to 40% by weight, in the water.
Such a compound is, for example, that sold under the name Natrlquest® E30 by Innospec Active Chemicals, at 37% by weight in water.
The composition according to the invention can comprise at least one glycol, preferably caprylyl glycol.
Preferably, the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.2% to 1.5% by weight, of glycol(s), with respect to the total weight of the composition.
The composition according to the invention can comprise at least one preservative. Mention may be made, among the preferred preservatives, of hydroxyacetophenone, phenoxyethanol and their mixtures. Preferably, the composition according to the invention comprises from 0.1% to 2% by weight, preferably from 0.5% to 1.5% by weight, more preferentially from 0.7% to 1% by weight, of preservative(s), with respect to the total weight of the composition.
Preferably, the composition of the present invention is transparent. The term “transparent composition” is understood to mean, within the meaning of the present invention, a composition exhibiting a turbidity value of less than 200 NTU, preferably of less than 150 NTU, preferably of less than 100 NTU. Preferably, the turbidity of the compositions is at least equal to 1 NTU.
The NTU (nephelometric turbidity unit) is the unit of measurement of the turbidity of a composition. The measurement of the turbidity is carried out, for example, with a 21 OOP model turbidimeter from Hach, the tubes used for the measurement being referenced AR397A cat 24347-06. The measurements are carried out at ambient temperature (from 20°C to 25°C).
Preferably, the composition is transparent and exhibits a turbidity value of between 1 and 200 NTU, preferably between 1 and 150 NTU, preferably of less than 100 NTU.
Finally, the invention also relates to a cosmetic method for caring for keratin materials, preferably the skin, comprising the application, to said keratin materials, of a composition according to the invention.
Concrete but in no way limiting examples illustrating the invention will now be given.
EXAMPLES
In the examples, the pressure is atmospheric pressure, unless otherwise indicated. Unless otherwise mentioned, the percentages are expressed by weight, with respect to the total weight of composition (% w/w). Example 1 : Influence of water-soluble UV screening agent on the stabilization of the color of an aqueous solution comprisinq 10% and 12% bv weiqht of vitamin C
The preparation is carried out of gelled aqueous solutions comprising 10% or 12% by weight of ascorbic acid, having a pH equal to 6, the pH having been adjusted with sodium hydroxide (NaOH);
- comprising 2-phenylbenzimidazole-5-sulfonic acid (I NCI name: Phenylbenzimidazole Sulfonic Acid) at 1% or 0.75% by weight (Formulae A and C according to the invention);
- comprising a water-soluble UVA screening agent, outside the definition of water-soluble UV screening agents according to the present invention, which is Terephthalylidene Dicamphor Sulfonic Acid available under the name Mexoryl SX from Chimex (comparative Formula B); comprising 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (I NCI name:
Hydroxyethylpiperazine Ethane Sulfonic Acid or HEPES) (comparative Formula C). A test of stability of the solutions is carried out for 15 days, 1 month and 2 months at 45°C.
The results show that the replacement of 2-phenylbenzimidazole-5-sulfonic acid (I NCI name: Phenylbenzimidazole Sulfonic Acid) by Terephthalylidene Dicamphor Sulfonic Acid (Mexoryl SX), a water-soluble UV screening agent outside the definition of the choice of the UV screening agents according to the invention, runs counter to the anticipated effect because the formula obtained is cloudy due to the presence of crystals and does not make it possible to resolve the issue of the invention, which is to obtain a transparent serum.
Terephthalylidene Dicamphor Sulfonic Acid (Mexoryl SX), which comprises a sulfonate functional group, is not compatible in terms of chemical stability of the compositions according to the invention comprising 1% by weight of ascorbic acid and thus does not make possible the reduction in color.
The results furthermore show that the replacement of 2-phenylbenzimidazole-5-sulfonic acid (INCI name: Phenylbenzimidazole Sulfonic Acid) by 4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid (HEPES), also containing a sulfonate functional group, runs counter to the anticipated effect, that is to say that there is a deterioration in the color, which is increasingly dark (> 4 on the color scale).
The condition of a pH of 6 is not sufficient to stabilize the color of an aqueous solution of vitamin C.
Not all water-soluble UV screening agents or compounds exhibiting a sulfonate functional group are effective in this functionality.
Surprisingly, for the compositions according to the invention, Formulae 1 and C, the solutions obtained are all stable, in particular after storage at 45°C for 2 months, and show an acceptable loss of vitamin C.
The combination of sodium hydroxide or potassium hydroxide with a water-soluble UV screening agent according to the invention, such as benzimidazole derivatives comprising at least one sulfonic radical, for example 2-phenylbenzimidazole-5-sulfonic acid (I NCI name: Phenylbenzimidazole Sulfonic Acid), makes it possible to stabilize the color of solutions of vitamin C.
Only the water-soluble UV screening agents according to the invention, such as benzimidazole derivatives comprising at least one sulfonic radical, make it possible simultaneously to combine the stabilization of the color and the achievement of a completely transparent serum.
Example 3: Compositions according to the invention
The Formulae E to J according to the invention below are prepared according to the following protocol:
Phase A: in the main reactor:
1. The water is inserted at ambient temperature.
2. The ascorbic acid is inserted and mechanical stirring is carried out.
3. NaOH is added and adjusting is carried out to bring the pH to 5.8.
4. The polyquaternium-67 is added and stirring is carried out for 10 min.
Phase B: in an auxiliary reactor:
1. The water and the different compounds of phase B are inserted, then heating is carried out to 60°C and stirring is carried out for 10 min.
2. The temperature is brought back again to 25°C.
Phase C: in an auxiliary reactor:
1. The water and the 2-phenylbenzimidazole-5-sulfonic acid are inserted and then stirring is carried out.
2. The sodium hydroxide is added and then there is a wait for the solution to become clear/colorless (with a pH of 6.22 ± 0.3). Combining of the phases (in the main reactor):
The 3 phases are combined in the main vessel and the q.s. is made with water.
[Table 2]
a.m. : active material
The compositions E to J according to the invention comprising at least one water- soluble UV screening agent defined according to the invention, in particular benzimidazole derivatives comprising at least one sulfonic radical, such as 2-phenylbenzimidazole-5- sulfonicacid (I NCI name: Phenylbenzimidazole Sulfonic Acid), and which can also comprise at least one cationic polymer, such as cationic cellulose polymers (Polyquaternium-67), and optionally in addition at least one sugar alcohol, such as maltitol and/or sorbitol, exhibit a stabilization of the color while being completely transparent.
The compositions according to the invention exhibit in particular the following properties:
- maintenance of the transparency at 1 (scale from 1 to 3: 1 being transparent, 2 translucent, 3 opaque) over time and at temperature (after 2 months at 4°C, ambient temperature and 45°C);
- no or slight emission of gas which is acceptable, that is to say release of CO2 due to the decomposition of the ascorbic acid over time and at temperature (after 2 months at
4°C, ambient temperature and 45°C);
- no crystals observed macroscopically and microscopically over time and at temperature (after 2 months at 4°C, ambient temperature and 45°C); and
- physicochemical stability over time and at temperature (after 2 months at 4°C, ambient temperature and 45°C).
Claims
1. A cosmetic composition comprising:
- at least 30% by weight of water, with respect to the total weight of the composition,
- at least 5% by weight of ascorbic acid, with respect to the total weight of the composition,
- at least one water-soluble UV screening agent chosen from bis-benzazolyl derivatives, benzimidazole derivatives comprising at least one sulfonic radical, p-aminobenzoic acid derivatives and their mixtures, said composition having a pH of between 5 and 7.
2. The composition as claimed in claim 1, characterized in that it additionally comprises at least one cationic polymer chosen from cationic galactomannan gums and cationic cellulose polymers modified by groups comprising at least one linear fatty chain.
3. The composition as claimed in claim 1 or claim 2, characterized in that it comprises from 30% to 93% by weight of water, with respect to the total weight of the composition, more preferentially from 50% to 90%, more preferentially still from 55% to 70%.
4. The composition as claimed in one of claims 1 to 3, characterized in that it comprises at least one organic solvent which is soluble in water, at 25°C, chosen from alcohols, polyols and their mixtures; preferably chosen from C1-C10 alcohols, more preferentially C1-C5 alcohols, such as ethanol, isopropanol, propanol and butanol, and polyols having from 2 to 20 carbon atoms, more preferentially from 2 to 6 carbon atoms, such as glycerol, diglycerol, propylene glycol, isoprene glycol, dipropylene glycol, butylene glycol, hexylene glycol, 1,3-propanediol, pentylene glycol, polyethylene glycols having from 2 to 200 ethylene oxide units and their mixtures.
5. The composition as claimed in one of claims 1 to 4, characterized in that it comprises at least 7% by weight of ascorbic acid, with respect to the total weight of the composition; preferably, the composition comprises from 5% to 30% by weight of ascorbic acid, with respect to the total weight of the composition, more preferentially from 7% to 20% by weight.
6. The composition as claimed in one of claims 2 to 5, characterized in that the cationic polymer is chosen from guar gums comprising trialkylammonium cationic
groups and quaternized hydroxyethylcelluloses modified by groups comprising at least one linear fatty chain; preferably from hydroxyethylcelluloses of formula (lb) in which R represents the trimethylammonium halide and R1 represents the dimethyldodecylammonium halide [Chem 2]
and preferably from guar hydroxypropyl trimethylammonium chloride and hydroxyethylcelluloses which have reacted with a trimethylammonium epoxide and a lauryldimethylammonium epoxide (INCI name: Polyquaternium-67).
7. The composition as claimed in one of claims 2 to 6, characterized in that it comprises from 0.05% to 5% by weight of active material of cationic polymer, with respect to the total weight of the composition, more preferentially from 0.3% to 3% by weight, more preferentially still from 0.4% to 2% by weight.
8. The composition as claimed in one of claims 1 to 7, characterized in that the water-soluble UV screening agent(s) is(are) chosen from benzimidazole derivatives comprising at least one sulfonic radical.
9. The composition as claimed in claim 8, characterized in that the benzimidazole derivative comprising at least one sulfonic radical is 2-phenylbenzimidazole- 5-sulfonic acid (INCI name: Phenylbenzimidazole Sulfonic Acid).
10. The composition as claimed in one of claims 1 to 9, characterized in that it comprises from 0.1% to 3% by weight of active material of water-soluble UV screening agent, with respect to the total weight of the composition, more preferentially 0.2% to 1% from by weight, more preferentially still from 0.75% to 0.9% by weight.
11. The composition as claimed in one of claims 1 to 10, characterized in that it additionally comprises at least one sugar alcohol, preferably maltitol and/or sorbitol, in particular comprises maltitol and sorbitol.
12. The composition as claimed in one of claims 1 to 11 , characterized in that it comprises from 0.05% to 5% by weight of active material of sugar alcohol, with respect to the total weight of the composition, more preferentially from 0.075% to 3% by weight, more preferentially still from 0.15% to 2.25% by weight.
13. The composition as claimed in one of claims 1 to 12, characterized in that the pH of the composition is between 5.5 and 6.5.
14. The composition as claimed in one of claims 1 to 13, characterized in that it comprises at least one base; preferably, the base of the composition is an alkali metal hydroxide, preferably sodium hydroxide or potassium hydroxide, and more preferentially sodium hydroxide.
15. The composition as claimed in one of claims 1 to 14, characterized in that it comprises at least one additive chosen from active principles, sequestering agents, glycols, preservatives and fragrances; preferably, it comprises at least one sequestering agent chosen from salts of ethylenediaminedisuccinic acid, and/or at least one glycol which is preferably caprylyl glycol, and/or at least one preservative, preferably chosen from hydroxyacetophenone, phenoxyethanol and their mixtures.
16. The composition as claimed in one of claims 1 to 15, characterized in that it is transparent.
17. A cosmetic method for caring for keratin materials, preferably the skin, comprising the application, to said keratin materials, of a composition as claimed in one of claims 1 to 16.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FRFR2106948 | 2021-06-28 | ||
FR2106948A FR3124389A1 (en) | 2021-06-28 | 2021-06-28 | Transparent cosmetic composition with ascorbic acid and water-soluble UV filter |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023275083A1 true WO2023275083A1 (en) | 2023-01-05 |
Family
ID=78649345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/067783 WO2023275083A1 (en) | 2021-06-28 | 2022-06-28 | Transparent cosmetic composition with ascorbic acid and water-soluble uv screening agent |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3124389A1 (en) |
WO (1) | WO2023275083A1 (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
US3589578A (en) | 1968-01-20 | 1971-06-29 | Monforts Fa A | Tension-relieving device for stretchable sheet material |
US4031307A (en) | 1976-05-03 | 1977-06-21 | Celanese Corporation | Cationic polygalactomannan compositions |
EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
US5455035A (en) * | 1994-01-13 | 1995-10-03 | Elizabeth Arden Company, Division Of Conopco, Inc. | Clear two-phase cosmetic composition |
US20020055532A1 (en) * | 2000-06-23 | 2002-05-09 | Merck Patent Gesellschaft | UV-B filter |
US20020136771A1 (en) * | 1998-12-31 | 2002-09-26 | Amitee Cosmetics, Inc. | Stabilized ascorbic acid composition |
US20040081629A1 (en) * | 2002-08-22 | 2004-04-29 | Schering Plough Healthcare Products, Inc. | Stabilized photoprotective composition |
US20080233076A1 (en) * | 2007-03-21 | 2008-09-25 | L'oreal | Process for stabilizing ascorbic acid compositions |
KR20160112721A (en) * | 2015-03-20 | 2016-09-28 | 김주호 | Cosmetic composition |
KR102184317B1 (en) * | 2020-02-07 | 2020-11-30 | 윤명석 | A complex materials for antiwrinkle and skin whitening |
-
2021
- 2021-06-28 FR FR2106948A patent/FR3124389A1/en active Pending
-
2022
- 2022-06-28 WO PCT/EP2022/067783 patent/WO2023275083A1/en unknown
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2463264A (en) | 1942-12-23 | 1949-03-01 | Ciba Ltd | Derivatives of cyclic amidines and process of making same |
US3589578A (en) | 1968-01-20 | 1971-06-29 | Monforts Fa A | Tension-relieving device for stretchable sheet material |
US4031307A (en) | 1976-05-03 | 1977-06-21 | Celanese Corporation | Cationic polygalactomannan compositions |
US5455035A (en) * | 1994-01-13 | 1995-10-03 | Elizabeth Arden Company, Division Of Conopco, Inc. | Clear two-phase cosmetic composition |
EP0669323A1 (en) | 1994-02-24 | 1995-08-30 | Haarmann & Reimer Gmbh | Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation |
US20020136771A1 (en) * | 1998-12-31 | 2002-09-26 | Amitee Cosmetics, Inc. | Stabilized ascorbic acid composition |
US20020055532A1 (en) * | 2000-06-23 | 2002-05-09 | Merck Patent Gesellschaft | UV-B filter |
US20040081629A1 (en) * | 2002-08-22 | 2004-04-29 | Schering Plough Healthcare Products, Inc. | Stabilized photoprotective composition |
US20080233076A1 (en) * | 2007-03-21 | 2008-09-25 | L'oreal | Process for stabilizing ascorbic acid compositions |
KR20160112721A (en) * | 2015-03-20 | 2016-09-28 | 김주호 | Cosmetic composition |
KR102184317B1 (en) * | 2020-02-07 | 2020-11-30 | 윤명석 | A complex materials for antiwrinkle and skin whitening |
Non-Patent Citations (1)
Title |
---|
"Kirk-Othmer Encyclopedia of Chemical Technology", 2005, JOHN WILEY AND SONS, article "Sugar Alcohols" |
Also Published As
Publication number | Publication date |
---|---|
FR3124389A1 (en) | 2022-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6813586B2 (en) | Aerosol dandruff prevention composition | |
EP2402000B1 (en) | Low-irritating, clear cleansing compositions with relatively low pH | |
ES2538081T3 (en) | Polyglyceryl compounds and compositions | |
US6362146B1 (en) | Personal washing compositions | |
US8546559B2 (en) | Modified galactomannan ethers | |
US20160310389A1 (en) | Low Viscosity Hair Care Composition | |
IE53380B1 (en) | Detergent compounds and compositions | |
MX2007016588A (en) | Structured surfactant compositions. | |
US11752082B2 (en) | Cosmetic composition for the oxidative dyeing of keratin fibres | |
KR20150056775A (en) | Hair care polymer | |
EA022230B1 (en) | Clear liquid composition comprising alkanoyl glycinate, amphoteric, alkyl sulfate and specific acrylate polymers | |
WO2023275083A1 (en) | Transparent cosmetic composition with ascorbic acid and water-soluble uv screening agent | |
JP6953604B1 (en) | Ascorbic acid compound-containing composition | |
WO2021194806A1 (en) | Skin cleansing formulation | |
CN109152712A (en) | Cosmetic composition and cosmetic treatment method comprising anionic surfactant, amphoteric surfactant, cationic polymer and the liquid fatty substance selected from fatty alcohol and fatty ester | |
WO2023275073A1 (en) | Transparent cosmetic composition with ascorbic acid and a specific cationic polymer | |
WO2023275046A1 (en) | Transparent cosmetic composition with ascorbic acid, a cationic polymer and a glycol | |
CN107109310A (en) | Transparent liquid soap | |
WO2023158591A1 (en) | Personal care pod | |
WO2022203862A1 (en) | Shampoo formulation with enhanced silicone deposition | |
WO2022270014A1 (en) | Skin cleaning agent composition | |
BR112012033245B1 (en) | Clear, low irritation skin cleansing compositions with relatively low pH |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22740817 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |